RESULTS
Of the 61 patients who received at least one dose of remdesivir, data from 8 could not be analyzed (including 7 patients with no post-treatment data and 1 with a dosing error). Of the 53 patients whose data were analyzed, 22 were in the United States, 22 in Europe or Canada, and 9 in Japan. At baseline, 30 patients (57%) were receiving mechanical ventilation and 4 (8%) were receiving extracorporeal membrane oxygenation. During a median follow-up of 18 days, 36 patients (68%) had an improvement in oxygen-support class, including 17 of 30 patients (57%) receiving mechanical ventilation who were extubated. A total of 25 patients (47%) were discharged, and 7 patients (13%) died; mortality was 18% (6 of 34) among patients receiving invasive ventilation and 5% (1 of 19) among those not receiving invasive ventilation. CONCLUSIONS
In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy. (Funded by Gilead Sciences.)
随便看看
- 女性尿路感染,指南教你如何用药
- 可能性很大,厉害国喜欢把实验室的动物标本卖给草民吃
- 美国空军的X-37B,可带6枚核弹,具有核打击任务,被用来消灭敌方卫星
- 经口内镜下肌切开术后胃食管反流患病率高达 88%,情况不容忽视
- 皮肤影像发展迅猛,助力疾病诊断
- 选结束,美国医学会批准羟氯喹治疗新冠,因为它不在帮助川普
- 新冠病毒和疫苗的致命真相曝光,疫苗可能比病毒更危险...
- 植物人县长的苏醒
- 吃鸡蛋的真相
- 记住别人的好,修了自己的德!
- 突发!福奇900封邮件爆雷,疫情真相呼之欲出!真正的危机还没
- 男星高以翔猝死疑因“运动过量”,更有众多球星死于这原因,常人如何防范?
- 公共泳池练游泳?请记住这四条!
- 是减肥瘦身的天使?还是导致营养不良的魔鬼?关于代餐的专业科普
- 因邮件丑闻曝光福齐博士形象一落千丈,美国民众和官员声讨福齐
- 2019 年 ADA 糖尿病诊疗标准